Hypertension in patients presenting with stroke

被引：4
作者：
Pearson B.J. [1 ]
Bath P.M.W. [1 ]
Spence D. [2 ]
机构：
[1] Division of Stroke Medicine, University of Nottingham, Nottingham NG5 1PB, Hucknall Road
[2] Stroke Prevention and Atherosclerosis Research Centre, Robarts Research Institute, London, ON N6G 2V2
来源：
Current Hypertension Reports | 2000年 / 2卷 / 6期
关键词：
Acute Stroke; Nimodipine; Systolic Hypertension; Eprosartan; Naftidrofuryl;
D O I：
10.1007/s11906-996-0040-9
中图分类号：
学科分类号：
摘要：
Hypertension is a major risk factor for stroke disease. There is now some international agreement on what constitutes hypertension, and at what level of blood pressure treatment is required. Large randomised controlled trials demonstrate the benefit of reducing blood pressure for the primary and secondary prevention of stroke disease. Studies have also demonstrated the benefit of particular classes of antihypertensive agents in certain patient groups. Research is beginning to elucidate the problems of hypertension in the acute phase of ischaemic stroke and the therapeutic strategies that may be helpful. Given the significant impact of stroke disease on all health services, it remains an important priority to determine the best management of hypertension in stroke. Copyright © 2000 by Current Science Inc.
引用
收藏
页码：551 / 557
页数：6
相关论文
共 66 条
[1]  
Bulpitt C.J., Controlling hypertension in the elderly, Q J Med, 93, pp. 203-205, (2000)
[2]  
Fletcher A.E., Bulpitt C.J., How far should blood pressure be lowered?, N Engl J Med, 326, pp. 251-254, (1992)
[3]  
Hansson L., Zanchetti A., Carruthers S.G., Et al., Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: Principle results of the Hypertension Optimal Treatment (HOT) randomised trial, Lancet, 351, pp. 1755-1762, (1998)
[4]  
Mallion J.M., Baguet J.P., Siche J.P., Et al., Influence of some parameters on the blood pressure reduction under treatment: Experience from the Hypertension Optimal Treatment Study, Archives des Maladies du Coeur et des Vaisseaux, 91, pp. 1049-1053, (1998)
[5]  
Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group, JAMA, 265, pp. 3255-3264, (1991)
[6]  
Spence J.D., Pseudohypertension, Hypertension: Pathophysiology, Diagnosis and Management, pp. 1929-1937, (1995)
[7]  
Fagard R.H., Staessen J.A., Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension, Lancet, 350, pp. 757-764, (1997)
[8]  
Voko Z., Bots M.L., Hofman A., Et al., J-shaped relation between blood pressure and stroke in treated hypertensives, Hypertension, 34, pp. 1181-1185, (1999)
[9]  
Klungel O.H., Stricker B.H., Paes A.H., Et al., Excess stroke among hypertensive men and women attributable to undertreatment of hypertension, Stroke, 30, pp. 1312-1318, (1999)
[10]  
Liu L., Wang J.G., Gong L., Et al., Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension, J Hypertens, 16, pp. 1823-1829, (1998)
1234567